EICHOR
● Not Yet Recruiting
Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis · Sponsor: InSilico Medicine Hong Kong Limited
About this study
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of Rentosertib (INS018\_055) administered orally in Patients with Idiopathic Pulmonary Fibrosis. The purpose of this study is to evaluate if Rentosertib (INS018\_055) works to treat patients with Idiopathic Pulmonary Fibrosis in adults. It will also learn about the safety of Rentosertib (INS018\_055). In this study, Rentosertib (INS018\_055) will be compared to a placebo (a look-alike substance that contains no drug) to investigate if Rentosertib (INS018\_055) works to treat Idiopathic Pulmonary Fibrosis.
This description comes directly from the study's public registry record.
Talk to the study team
Qinhan Chen · +86 021-50831718 · Insilico-Clinicaltrial@insilico.ai
Always discuss trial participation with your own doctor first.
Locations (47)
| Anhui Chest Hospital | Hefei, Anhui, China | — |
| Anhui Provincial Hospital | Hefei, Anhui, China | — |
| Beijing Chaoyang Hospital, Capital Medical University | Beijing, Beijing Municipality, China | — |
| Beijing Friendship Hospital, Capital Medical University | Beijing, Beijing Municipality, China | — |
| Peking Union Medical College Hospital | Beijing, Beijing Municipality, China | — |
| Fuzhou University Affiliated Provincial Hospital | Fuzhou, Fujian, China | — |
| The Second Affiliated Hospital of Xiamen Medical College | Xiamen, Fujian, China | — |
| Nanfang Hospital, Southern Medical University | Guangzhou, Guangdong, China | — |
| The First Affiliated Hospital of Guangzhou Medical University | Guangzhou, Guangdong, China | — |
| The First Affiliated Hospital of Guangxi Medical University | Nanning, Guangxi, China | — |
| Hainan General Hospital | Haikou, Hainan, China | — |
| Hebei Medical University Third Hospital | Shijiazhuang, Hebei, China | — |
+ 35 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07687459